34 results
Explanation of the differences between depolarizing and nondepolarizing paralytic agents commonly used in anesthetic induction with
#pharmacology #mechanism ... #anesthesia #anesthesiology ... #medication #drugs ... Pharmacology of ... neuromuscular blocking drugs
IDSA - Doses of Drugs for Treatment of Adults and Children with Multidrug-Resistant Tuberculosis
Step 1 Levofloxacin,
IDSA - Doses of ... Drugs for Treatment ... antimicrobials #pharmacology ... #dosing #idsa # ... drugs
As a follow up to a previously uploaded infographic delineating indications for the widely-used induction agents
the widely-used induction ... management #anesthesia #anesthesiology ... #sideeffects #treatment ... /www.webmd.com/drugs ... Effects, Dosages, Treatment
IDSA Treatment Recommendations for Cryptococcal Meningoencephalitis in Human Immunodeficiency Virus Infected Individuals
Induction therapy:
 • AmBd (0.7–1.0
IDSA Treatment Recommendations ... Alternatives for induction ... Meningoencephalitis #IDSA ... #Treatment #management ... #cryptococcus #HIVAIDS
Induction agents used in anesthesia play a key role in the eventual sedation of the patient,
Induction agents ... clinical #management #anesthesiology ... reference.medscape.com/drug ... Effects, Dosages, Treatment ... consumer_propofol_diprivan/drugs-condition.htm
IDSA - Clinical Strategy to Build an Individualized Treatment Regimen for Multi-Drug Resistant Tuberculosis (MDR-TB)
 •
IDSA - Clinical ... Individualized Treatment ... MDRTB #management #Treatment ... antimicrobials #regimens #pharmacology ... #dosing #idsa #
Neurological Side Effects of Antipsychotic Drugs
Acute dystonia - Spasm of muscles of tongue, face, neck, back
Antipsychotic Drugs ... risk • Tx: Dose reduction ... months or years of treatment ... months or years of treatment ... #SideEffects #pharmacology
IDSA Recommendations for Preventing and Treating Penicillium marneffei Infections in HIV-AIDS
Preventing 1st Episode of Penicilliosis (Primary
IDSA Recommendations ... Penicilliosis #IDSA ... #Prevention #Treatment ... opportunistic #infections #HIVAIDS ... #pharmacology
IDSA Recommendations for Preventing and Treating Chagas Disease (American Trypanosomiasis) in HIV-AIDS
Preventing Clinical Disease
Indication:  Individuals
IDSA Recommendations ... Disease Note: Treatment ... Trypanosomiasis #IDSA ... opportunistic #infections #HIVAIDS ... #pharmacology
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS
Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days)
Preferred
IDSA Recommendations ... for effective treatment ... candida #mucosal #IDSA ... opportunistic #infections #HIVAIDS ... #pharmacology